Australia & NZ
Free Newsletter
 
16,000 subscribers! Example

News Article
Print Send Article Subscribe Bookmark and Share



Scientists develop drug to prevent transplant rejection


8/02/2010 - Australian scientists have developed a technique to stop people's bodies rejecting transplanted veins used in heart bypass surgery, a report says.

The Sydney Morning Herald says that researchers at the University of NSW have developed a new class of drug, made from DNA enzymes, which acts on the DNA in the cells of veins to permanently switch off the urge to reject.

The drug, known as DNAzyme, has only been used on rabbits but clinical trials are expected to start in April and researchers are confident the drug will change the face of cardiac surgery, the report says.

Source: AAP NewsWire

Browse the MedicalSearch directory: Research & Development

Most Popular 
A native grass used by indigenous Australians as a traditional remedy ...
Prime Minister Kevin Rudd has released his landmark plan for the ailing ...
Forget for a moment that public hospitals can't cope with rising demand ...
An independent review will examine how a man who was not a qualified ...
A review of popular parenting and mental health websites has shown how, ...
Australian scientists have studied how the brain is constructed to gain ...
The mother of a Network Ten newsreader who jumped off The Gap says ...
The federal government's plan to take control of hospital funding will ...
The swine flu pandemic in Australia has been equated to a bad year for ...
Australian women who are intending to fall pregnant should be taking an ...

 
Send this article to a colleague

 
To:  
  
From:  
   
Message:
(Optional)
 
Confirm:  
Protected by FormShield